The HSP90 Inhibitor, AT13387, Is Effective against Imatinib-Sensitive and -Resistant Gastrointestinal Stromal Tumor ModelsTomoko Smyth, Nicola G. Wallis, Thomas Van Looy et al.|Molecular Cancer Therapeutics|2012Cited by 59
Supplementary Figure Legend from The HSP90 Inhibitor, AT13387, Is Effective against Imatinib-Sensitive and -Resistant Gastrointestinal Stromal Tumor ModelsTomoko Smyth, Nicola G. Wallis, Thomas Van Looy et al.|Unknown|2023Cited by 0
Supplementary Figure 1 from The HSP90 Inhibitor, AT13387, Is Effective against Imatinib-Sensitive and -Resistant Gastrointestinal Stromal Tumor ModelsTomoko Smyth, Nicola G. Wallis, Thomas Van Looy et al.|Unknown|2023Cited by 0
Supplementary Figure Legend from The HSP90 Inhibitor, AT13387, Is Effective against Imatinib-Sensitive and -Resistant Gastrointestinal Stromal Tumor ModelsTomoko Smyth, Nicola G. Wallis, Thomas Van Looy et al.|Unknown|2023Cited by 0
Supplementary Figure 2 from The HSP90 Inhibitor, AT13387, Is Effective against Imatinib-Sensitive and -Resistant Gastrointestinal Stromal Tumor ModelsTomoko Smyth, Nicola G. Wallis, Jayne Curry et al.|Unknown|2023Cited by 0